Tap on and choose 'Add to Home Screen' to create a shortcut app

Tap on and choose 'Install/Install App' to create a shortcut app

Outcome for Medulloblastomas in Children

This page was last updated on May 9th, 2017

Survival After Initial Treatment

  • Average risk: The 5-year progression-free survival for children with an average-risk tumor is as high as 90%.
  • High risk: Even for children with high-risk tumors, the 5-year progression-free survival may exceed 80% (17).

Recurrent Medulloblastoma

  • Lower survival rate:  A much lower survival rate is associated with recurrence, with previous reports of a 5-year survival rate of 30% after high-dose chemotherapy with stem-cell rescue (4).

Functional Status

  • Side effects of therapies: Survivors have an increased risk of cognitive decline, endocrinopathies, second malignancies, and a variety of additional complications associated with both radiation therapy and chemotherapy (6, 9, 10, 16).

Your donations keep us going

The ISPN Guide is free to use, but we rely on donations to fund our ongoing work and to maintain more than a thousand pages of information created to disseminate the most up-to-date knowledge in the field of paediatric neurosurgery.

By making a donation to The ISPN Guide you are also indirectly helping the many thousands of children around the world whose treatment depends on well-informed surgeons.

Please consider making a donation today.

Use the app

The ISPN Guide can be used as a standalone app, both on mobile devices and desktop computers. It’s quick and easy to use.

Fully featured

Free registration grants you full access to The Guide and host of featured designed to help further your own education.

Stay updated

The ISPN Guide continues to expand both in breadth and depth. Join our mailing list to stay up-to-date with our progress.